(HealthDay)—Male and female general practitioners (GPs) prescribe analgesics to older patients in a similar manner but differ in their prescribing habits for antineuropathic pain drugs and symptomatic slow-acting drugs for osteoarthritis, according to a study published online Dec. 17 in Pain Medicine.
In a cross-sectional observational study, Aida Lazkani, Pharm.D., from the University Paris-Sud, and colleagues examined the relationship between GP gender and prescribing practice of chronic pain medications in older adults. Data were collected for 260 GPs, as well as 1,379 patients older than 65 years suffering from chronic pain.
The researchers found that for World Health organization step 1, step 2, and step 3 analgesics, there was no significant difference for female and male GP prescriptions. Compared with females, male GPs were more likely to prescribe antineuropathic pain drugs (11.3 versus 4.8 percent; P = 0.004) and less likely to prescribe symptomatic slow-acting drugs for osteoarthritis (10.2 versus 18.8 percent; P = 0.0003). These findings persisted after adjustment for several confounding variables (odds ratios, 2.43 [P = 0.02] and 0.64 [P = 0.03], respectively).
"Our results need to be confirmed in other pharmacoepidemiologic studies performed in different countries where prescribing practices might differ," the authors write.
Several authors disclosed financial ties to the pharmaceutical industry.
Explore further: GP guidelines needed for chronic pain treatment
More information: Abstract
Full Text (subscription or payment may be required)
Copyright © 2015 HealthDay. All rights reserved.
Medical Xpress on facebook
Related Stories
GP guidelines needed for chronic pain treatment
Nov 10, 2014
Some patients with chronic pain could be better served by being prescribed vitamin D supplements by their GP, according to research at the University of Adelaide.
Biomarkers ID disease activity in elderly with low back pain
Nov 13, 2014
(HealthDay)—Serum biomarkers can be used for assessment of active disease in older patients with low back pain, according to a study published online Nov. 3 in the Journal of the American Geriatrics So ...
Study confirms that doctors prescribe more painkillers to women
Oct 06, 2014
Regardless of the pain type, age and social class, women are more likely to be prescribed analgaesia than men. This is confirmed by a study conducted by several members of the Research Group on Public Health ...
Recommendations for managing pain in inflammatory arthritis
Dec 03, 2014
(HealthDay)—Recommendations have been developed for the management of pain in adults with optimally treated inflammatory arthritis, according to an article published in the September issue of the International Jo ...
Pain in knee osteoarthritis differs by ethnicity
May 09, 2014
(HealthDay)—Clinical pain and experimental pain differ by race and ethnicity among older adults with knee osteoarthritis (OA), according to research published online April 11 in Arthritis & Rheumatology.
Recommended for you
Merck seeks new OK for cancer drug, reorganization on track
11 hours ago
Drugmaker Merck & Co. is ratcheting up its race with rival Bristol-Myers Squibb Co. for leadership in one of today's hottest research areas, immuno-oncology, which harnesses the immune system to fight cancer.
Fish peptide could help in battle against cardiovascular disease
18 hours ago
A major international review of a peptide originally found in fish that could be used in the battle against cardiovascular disease has been published.
New method of finding drugs more important than new antibiotic itself
20 hours ago
It was big news this week when Nature published the discovery of a new antibiotic, teixobactin. Teixobactin, which kills bacteria by a different pathway than other antibiotics, represented the first new class of antibiotics to ...
Shire to buy specialty drugmaker NPS Pharma for $5.2 billion
Jan 11, 2015
Irish drugmaker Shire PLC said Sunday it will pay $5.2 billion to acquire NPS Pharmaceuticals Inc., which specializes in drugs for rare conditions.
US fines Japanese pharma co $39 mn for doctor kickbacks
Jan 09, 2015
Daiichi Sankyo, the large Japanese pharmaceutical company, is being fined $39 million over kickbacks it paid doctors in the United States to prescribe its drugs, the US Justice Department said Friday.
Dolutegravir/abacavir/lamivudine: Considerable added benefit for some adults with HIV
Jan 09, 2015
Since September 2014, the fixed-dose combination of dolutegravir/abacavir/lamivudine (trade name Triumeq) has been approved for human immunodeficiency virus (HIV) infected adults and adolescents above 12 years of age. The ...
User comments
Please sign in to add a comment. Registration is free, and takes less than a minute. Read more
Click here to reset your password.
Sign in to get notified via email when new comments are made.
© Medical Xpress 2011-2014, Science X network
(HealthDay)—Male and female general practitioners (GPs) prescribe analgesics to older patients in a similar manner but differ in their prescribing habits for antineuropathic pain drugs and symptomatic slow-acting drugs for osteoarthritis, according to a study published online Dec. 17 in Pain Medicine.
In a cross-sectional observational study, Aida Lazkani, Pharm.D., from the University Paris-Sud, and colleagues examined the relationship between GP gender and prescribing practice of chronic pain medications in older adults. Data were collected for 260 GPs, as well as 1,379 patients older than 65 years suffering from chronic pain.
The researchers found that for World Health organization step 1, step 2, and step 3 analgesics, there was no significant difference for female and male GP prescriptions. Compared with females, male GPs were more likely to prescribe antineuropathic pain drugs (11.3 versus 4.8 percent; P = 0.004) and less likely to prescribe symptomatic slow-acting drugs for osteoarthritis (10.2 versus 18.8 percent; P = 0.0003). These findings persisted after adjustment for several confounding variables (odds ratios, 2.43 [P = 0.02] and 0.64 [P = 0.03], respectively).
"Our results need to be confirmed in other pharmacoepidemiologic studies performed in different countries where prescribing practices might differ," the authors write.
Several authors disclosed financial ties to the pharmaceutical industry.
Explore further: GP guidelines needed for chronic pain treatment
More information: Abstract
Full Text (subscription or payment may be required)
Copyright © 2015 HealthDay. All rights reserved.
Medical Xpress on facebook
Related Stories
GP guidelines needed for chronic pain treatment
Nov 10, 2014
Some patients with chronic pain could be better served by being prescribed vitamin D supplements by their GP, according to research at the University of Adelaide.
Biomarkers ID disease activity in elderly with low back pain
Nov 13, 2014
(HealthDay)—Serum biomarkers can be used for assessment of active disease in older patients with low back pain, according to a study published online Nov. 3 in the Journal of the American Geriatrics So ...
Study confirms that doctors prescribe more painkillers to women
Oct 06, 2014
Regardless of the pain type, age and social class, women are more likely to be prescribed analgaesia than men. This is confirmed by a study conducted by several members of the Research Group on Public Health ...
Recommendations for managing pain in inflammatory arthritis
Dec 03, 2014
(HealthDay)—Recommendations have been developed for the management of pain in adults with optimally treated inflammatory arthritis, according to an article published in the September issue of the International Jo ...
Pain in knee osteoarthritis differs by ethnicity
May 09, 2014
(HealthDay)—Clinical pain and experimental pain differ by race and ethnicity among older adults with knee osteoarthritis (OA), according to research published online April 11 in Arthritis & Rheumatology.
Recommended for you
Merck seeks new OK for cancer drug, reorganization on track
11 hours ago
Drugmaker Merck & Co. is ratcheting up its race with rival Bristol-Myers Squibb Co. for leadership in one of today's hottest research areas, immuno-oncology, which harnesses the immune system to fight cancer.
Fish peptide could help in battle against cardiovascular disease
18 hours ago
A major international review of a peptide originally found in fish that could be used in the battle against cardiovascular disease has been published.
New method of finding drugs more important than new antibiotic itself
20 hours ago
It was big news this week when Nature published the discovery of a new antibiotic, teixobactin. Teixobactin, which kills bacteria by a different pathway than other antibiotics, represented the first new class of antibiotics to ...
Shire to buy specialty drugmaker NPS Pharma for $5.2 billion
Jan 11, 2015
Irish drugmaker Shire PLC said Sunday it will pay $5.2 billion to acquire NPS Pharmaceuticals Inc., which specializes in drugs for rare conditions.
US fines Japanese pharma co $39 mn for doctor kickbacks
Jan 09, 2015
Daiichi Sankyo, the large Japanese pharmaceutical company, is being fined $39 million over kickbacks it paid doctors in the United States to prescribe its drugs, the US Justice Department said Friday.
Dolutegravir/abacavir/lamivudine: Considerable added benefit for some adults with HIV
Jan 09, 2015
Since September 2014, the fixed-dose combination of dolutegravir/abacavir/lamivudine (trade name Triumeq) has been approved for human immunodeficiency virus (HIV) infected adults and adolescents above 12 years of age. The ...
User comments
Please sign in to add a comment. Registration is free, and takes less than a minute. Read more
Click here
to reset your password.
Sign in to get notified via email when new comments are made.
© Medical Xpress 2011-2014, Science X network
0 comments:
Post a Comment